GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (OTCPK:ALPMY) » Definitions » Days Inventory

Astellas Pharma (Astellas Pharma) Days Inventory

: 260.92 (As of Dec. 2023)
View and export this data going back to 2008. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). Astellas Pharma's Average Total Inventories for the three months ended in Dec. 2023 was $1,507 Mil. Astellas Pharma's Cost of Goods Sold for the three months ended in Dec. 2023 was $527 Mil. Hence, Astellas Pharma's Days Inventory for the three months ended in Dec. 2023 was 260.92.

The historical rank and industry rank for Astellas Pharma's Days Inventory or its related term are showing as below:

ALPMY' s Days Inventory Range Over the Past 10 Years
Min: 144.8   Med: 197.76   Max: 253.45
Current: 253.45

During the past 13 years, Astellas Pharma's highest Days Inventory was 253.45. The lowest was 144.80. And the median was 197.76.

ALPMY's Days Inventory is ranked worse than
77.95% of 975 companies
in the Drug Manufacturers industry
Industry Median: 157.9 vs ALPMY: 253.45

Astellas Pharma's Days Inventory increased from Dec. 2022 (197.41) to Dec. 2023 (260.92). It might indicate that Astellas Pharma's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Astellas Pharma's Inventory Turnover for the three months ended in Dec. 2023 was 0.35.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Astellas Pharma's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.51.


Astellas Pharma Days Inventory Historical Data

The historical data trend for Astellas Pharma's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Days Inventory
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 191.36 196.38 234.77 239.52 219.58

Astellas Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Inventory Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 197.41 246.21 254.54 259.40 260.92

Competitive Comparison

For the Drug Manufacturers - General subindustry, Astellas Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Astellas Pharma Days Inventory Distribution

For the Drug Manufacturers industry and Healthcare sector, Astellas Pharma's Days Inventory distribution charts can be found below:

* The bar in red indicates where Astellas Pharma's Days Inventory falls into.



Astellas Pharma Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Astellas Pharma's Days Inventory for the fiscal year that ended in Mar. 2023 is calculated as

Days Inventory (A: Mar. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Mar. 2022 ) + Total Inventories (A: Mar. 2023 )) / count ) / Cost of Goods Sold (A: Mar. 2023 )*Days in Period
=( (1290.904 + 1304.657) / 2 ) / 2157.293*365
=1297.7805 / 2157.293*365
=219.58

Astellas Pharma's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

Days Inventory (Q: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Sep. 2023 ) + Total Inventories (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (1445.081 + 1569.507) / 2 ) / 527.13*365 / 4
=1507.294 / 527.13*365 / 4
=260.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Astellas Pharma  (OTCPK:ALPMY) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Astellas Pharma's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Astellas Pharma's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Astellas Pharma Days Inventory Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Astellas Pharma (Astellas Pharma) Business Description

Traded in Other Exchanges
Address
2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411
Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.